1315 Capital, LLC is a private equity investment firm formed in the state of Delaware and co-founded in 2014 by Partners Adele C. Oliva and Michael Koby (the “Co-Founders”). The Co-Founders collectively have over 40 years of private equity and growth investing experience. The Co-Founders are currently supported by 12 additional professionals and 7 Operating Team Members with broad financial experience. 1315 Capital, LLC maintains its principal office at 2929 Walnut Street, Suite 1240, Philadelphia, PA 19104. Types of Advisory Services - 1315 Capital, LLC and its affiliated relying advisers (collectively known as “1315 Capital” or “Adviser”) provide investment management services to pooled investment vehicles, typically limited partnerships (referred to throughout as the “Funds”), that make growth equity and growth buyout investments in commercial stage healthcare companies, including those in the areas of services, medical technology, pharma/medical technologies outsourcing, and health and wellness. 1315 Capital serves as the general partner and manager of eight private funds: 1315 Capital, L.P., 1315 Capital AIV, L.P., 1315 Capital II, L.P., 1315 Capital AIV II, L.P., 1315 Capital III, L.P., 1315 Capital III Parallel, L.P., 1315 Capital Emerging Growth & Buyout, L.P. and 1315 Capital Emerging Growth & Buyout Parallel, L.P. Additional information about these advisory services and types of clients is described immediately below and in Item 7. These investments employ a variety of structures and transaction types, including minority or majority ownership positions, growth capital, growth buyouts, Private Investments in Public Equity (“PIPEs”)

or some combination thereof. For additional information about these investment strategies please refer to Item 8. References herein to 1315 Capital may include, as the context requires, various entities controlled by 1315 Capital and through which 1315 Capital provides investment management services, such as entities that serve as general partners to its Funds. 1315 Capital’s only clients are the Funds, each of which is not registered under the Investment Company Act of 1940, as amended (the “1940 Act”), and whose securities are exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). No Funds’ shares are offered hereby and each Fund is open for investment through a “private placement” offering. The Funds are intended only for accredited investors, qualified clients and qualified purchasers, as defined under Federal securities laws. 1315 Capital provides investment advisory services to each Fund in accordance with the Fund’s limited partnership agreement, applicable advisory agreement and private placement memoranda. Investment advice is provided directly to each Fund, subject to the discretion and control of the Fund’s general partner, and not individually to any investor in the Funds. Investment guidelines and restrictions for each 1315 Capital Fund are established in the organizational and offering documents of the applicable Fund. 1315 Capital does not participate in wrap fee programs. Assets Under Management - 1315 Capital has discretionary authority with respect to investment decisions for the Funds and has $1,135,073,762 in regulatory assets under management as of December 31, 2023. 215.662.1315 | WWW.1315CAPITAL.COM 5